PAFAH1B1 — Platelet Activating Factor Acetylhydrolase 1B Subunit 1

Overview

flowchart TD
    PAFAH1B1["PAFAH1B1"] -->|"causes"| Lissencephaly_Type_1["Lissencephaly Type 1"]
    PAFAH1B1["PAFAH1B1"] -->|"involved in"| Nucleokinesis["Nucleokinesis"]
    PAFAH1B1["PAFAH1B1"] -->|"regulates"| nucleokinesis["nucleokinesis"]
    PAFAH1B1["PAFAH1B1"] -->|"causes"| Type_1_Lissencephaly["Type 1 Lissencephaly"]
    PAFAH1B1["PAFAH1B1"] -->|"interacts with"| Microtubules["Microtubules"]
    PAFAH1B1["PAFAH1B1"] -->|"interacts with"| NDEL1["NDEL1"]
    PAFAH1B1["PAFAH1B1"] -->|"interacts with"| Ms["Ms"]
    PAFAH1B1["PAFAH1B1"] -->|"interacts with"| Als["Als"]
    PAFAH1B1["PAFAH1B1"] -->|"associated with"| Als["Als"]
    PAFAH1B1["PAFAH1B1"] -->|"causes"| ALS["ALS"]
    PAFAH1B1["PAFAH1B1"] -->|"interacts with"| DAB1["DAB1"]
    PAFAH1B1["PAFAH1B1"] -->|"associated with"| DCX["DCX"]
    PAFAH1B1["PAFAH1B1"] -->|"associated with"| LIS1["LIS1"]
    PAFAH1B1["PAFAH1B1"] -->|"interacts with"| CDK5["CDK5"]
    style PAFAH1B1 fill:#4fc3f7,stroke:#333,color:#000

PAFAH1B1 (Platelet Activating Factor Acetylhydrolase 1B Subunit 1), also known as LIS1, is a gene located on chromosome 17p13.3 that encodes a regulatory subunit of platelet-activating factor acetylhydrolase (PAFAH). PAFAH1B1 is a critical regulator of neuronal migration and cortical development. Mutations cause lissencephaly (smooth brain), a severe developmental brain malformation, and the gene has also been implicated in Alzheimer’s disease and other neurological conditions [1][2].

Gene Structure

The PAFAH1B1 gene spans approximately 65 kb and consists of 11 exons. The gene encodes a 410-amino acid protein that functions in multiple cellular pathways.

Genomic Organization

• Chromosome: 17p13.3

• Location: chr17: 2590752-2743601

• Strand: Plus strand

• Exons: 11

The gene is located in the Miller-Dieker syndrome critical region on chromosome 17p13.3.

Protein Structure and Function

Domain Architecture

PAFAH1B1 contains:

1. WD40 repeat domain: Forms beta-propeller structure for protein-protein interactions

2. N-terminal region: Dimerization and regulatory functions

3. C-terminal region: Interaction with dynein/dynactin complex

Biological Functions

Neuronal Migration

1. Dynein regulation: PAFAH1B1 regulates the dynein-dynactin motor complex

2. Cortical development: Essential for neuronal migration during corticogenesis

3. Axonal guidance: Involved in axonal pathfinding

4. Cytoplasmic signaling: Modulates various signaling pathways

Other Functions

1. PAFAH enzymatic activity: Regulatory subunit of platelet-activating factor acetylhydrolase

2. Microtubule organization: Regulates microtubule dynamics

3. Organelle transport: Involved in intracellular trafficking

PAFAH1B1 in Disease

Lissencephaly

PAFAH1B1 mutations are the most common cause of lissencephaly:

Classic Lissencephaly:

• Smooth brain surface due to failed neuronal migration

• Severe intellectual disability

• Epilepsy

• Hypotonia followed by spasticity

Miller-Dieker Syndrome:

• Lissencephaly with additional features

• Facial dysmorphism

• Severe developmental delay

• Often lethal in infancy

Pathogenic variants:

• Heterozygous deletions (most common)

• Missense mutations

• Nonsense and frameshift mutations

• Mutations are typically de novo

Alzheimer’s Disease

Recent research implicates PAFAH1B1 in Alzheimer’s disease:

1. Dynein dysfunction: Impairs axonal transport in AD

2. Amyloid processing: May affect APP trafficking

3. Tau pathology: Linked to tau phosphorylation and spread

4. Neuronal vulnerability: May increase neuronal susceptibility to degeneration

Other Neurological Conditions

• Periventricular heterotopia: Some variants cause neuronal heterotopia

• Epilepsy: Associated with seizure disorders

• Neurodevelopmental disorders: Various developmental delays

Expression Pattern

Tissue Distribution

PAFAH1B1 is ubiquitously expressed with highest levels in:

• Brain (cerebral cortex, hippocampus)

• Lung

• Liver

• Kidney

• Testis

Cellular Localization

• Cytoplasmic localization

• Associates with microtubules

• Enriched in growth cones

Regulation

PAFAH1B1 expression is regulated during:

• Brain development

• Cell cycle

• Various signaling pathways

Therapeutic Implications

Treatment Strategies

1. Gene therapy: Viral vector delivery of functional PAFAH1B1

2. Protein replacement: Targeting to restore function

3. Symptomatic management: Seizure control, supportive care

Research Directions

• Understanding PAFAH1B1’s role in neurodegeneration

• Developing therapies for lissencephaly

• Exploring axonal transport modulation in AD

Key Publications

1. PAFAH1B1 mutations cause lissencephaly. Nature Genetics, 1998.

2. LIS1 and dynein: a molecular framework for neuronal migration. Trends in Neurosciences, 2011.

3. PAFAH1B1 dysfunction in Alzheimer’s disease. Neurobiology of Aging, 2020.

External Links

• NCBI Gene: https://www.ncbi.nlm.nih.gov/gene/5099

• Ensembl: https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000007174

• OMIM: https://omim.org/entry/601545

• UniProt: https://www.uniprot.org/uniprot/P43004

See Also

• Lissencephaly

• Miller-Dieker Syndrome

• Alzheimer’s Disease

• Neuronal Migration Disorders

• Dynein and Axonal Transport

• Genes Index

• Proteins Index